Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| 1-Deoxy-1-[(3, 4-dimethylphenyl)(1, 2, 3, 6-tetrahydro-2, 6-dioxo-4-pyrimidinyl)amino]-D-ribitol 2,3,4,5-Tetraacetate | 1-Deoxy-1-[(3, 4-dimethylphenyl)(1, 2, 3, 6-tetrahydro-2, 6-dioxo-4-pyrimidinyl)amino]-D-ribitol 2,3,4,5-Tetraacetate is an intermediate of 5-Deazariboflavin (D203220), which is utilized in photosensitized cleavage of thymine dimer, used in the study of the action of photoreactivation enzymes. It is also used in synthesis of 5-deazaflavin adenine dinucleotide (5-dFAD). Group: Biochemicals. Grades: Highly Purified. CAS No. 59389-71-8. Pack Sizes: 25mg, 50mg. Molecular Formula: C25H31N3O10. US Biological Life Sciences. |  Worldwide |
| 1-Deoxy-1-[(3,4-dimethylphenyl)amino]-D-ribitol | Riboflavin intermediate. Group: Biochemicals. Alternative Names: 1-Deoxy-1-(3,4-xylidino)-D-ribitol; 3,4-Dimethylphenyl-N-D-ribitylamine; NSC 122032; NSC 19654. Grades: Highly Purified. CAS No. 3051-94-3. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| 1-N-Ureido O-3-Deoxy-3-[ (2, 2, 2-trifluoroacetyl) amino]-α -D-glucopyranosyl- (1?6) -O-[2, 3, 6-trideoxy-2, 6-bis[[ (1, 1-dimethylethoxy) carbonyl]amino]-α -D-ribo-hexopyranosyl- (1?4) ]-2-deoxy-N3-[ (1, 1-dimethylethoxy) carbonyl]-D-streptamine | 1-N-Ureido O-3-Deoxy-3-[ (2, 2, 2-trifluoroacetyl) amino]-α -D-glucopyranosyl- (1?6) -O-[2, 3, 6-trideoxy-2, 6-bis[[ (1, 1-dimethylethoxy) carbonyl]amino]-α -D-ribo-hexopyranosyl- (1?4) ]-2-deoxy-N3-[ (1, 1-dimethylethoxy) carbonyl]-D-streptamine is an intermediate used in the synthesis of 1-N-Ureido Tobramycin Tetrahydrochloride Salt (U824490), which is the HCl salt form of 1-N-Ureido Tobramycin which is a related compound of Tobramycin (T524000), single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C36H61F3N6O17, Molecular Weight: 906.89. US Biological Life Sciences. | Worldwide |
| 1-N-Ureido O-3-Deoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-D-glucopyranosyl-(1?6)-O-[2,3,6-trideoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-N3-[(1,1-dimethylethoxy)carbonyl]-D-streptamine | 1-N-Ureido O-3-Deoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-D-glucopyranosyl-(1?6)-O-[2,3,6-trideoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-N3-[(1,1-dimethylethoxy)carbonyl]-D-streptamine is an intermediate used in the synthesis of 1-N-Ureido Tobramycin Tetrahydrochloride Salt, which is the HCl salt form of 1-N-Ureido Tobramycin which is a related compound of Tobramycin, single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial. Molecular formula: C35H61F3N6O17. Mole weight: 906.89. |  |
| 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin | 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin is a chemically modified cyclodextrin, vital in pharmaceutical applications. Its significant role lies in improving bioavailability and stability of drugs, particularly ones with low solubility. Additionally, it shows promise in cargo delivery for gene therapy. Synonyms: Octakis-(2,3-di-O-methyl-6-amino-6-deoxy)-γ-cyclodextrin. Molecular formula: C64H120N8O32. Mole weight: 1513.67. | |
| 2-Amino-2'-deoxy-N6,N6-dimethyl-2'-adenosine | 2-Amino-2'-deoxy-N6,N6-dimethyl-2'-adenosine is an intriguing biomedical agent, conquering the realm of antiviral mastery and enveloping RNA pathogens within its strategic web. Through an artful act of termination, this compound disrupts viral replication. Such fortitude emanates from its prowess in inhibiting viral polymerase activity, thwarting the insidious dance of their replication and gallantly diminishing the burden of viral load. Synonyms: 6-Dma-dguo; 6-Dimethylamino-2'-deoxyguanosine; Adenosine, 2-amino-2'-deoxy-N,N-dimethyl-; 2'-Deoxy-6-dimethylaminoguanosine; 2-Amino-6-(dimethylamino)-9-(2-deoxy-beta-D-ribofuranosyl)-9H-purine; 9-(2-Deoxypentofuranosyl)-2-imino-N,N-dimethyl-2,9-dihydro-1H-purin-6-amine. Grades: ≥95%. CAS No. 83061-20-5. Molecular formula: C12H18N6O3. Mole weight: 294.31. | |
| 2-Amino-N6,N6-dimethyl-2'-deoxy-2'-fluoro-beta-D-arabinoadenosine | 2-Amino-N6,N6-dimethyl-2'-deoxy-2'-fluoro-beta-D-arabinoadenosine, a powerful antiviral drug, has proven effective in controlling hepatitis C viral infections. Its potent mechanism of action involves binding to and inhibiting the viral RNA polymerase, thereby reducing viral replication, viral load and disease progression. Not content with tackling hepatitis C alone, this remarkable compound has also been investigated for its potential use against HIV, influenza and even select cancers like chronic lymphocytic leukemia. Its versatility and unique mechanism of action make 2-Amino-N6,N6-dimethyl-2'-deoxy-2'-fluoro-beta-D-arabinoadenosine a valuable addition to any clinician's armamentarium in the battle against viral infections and other diseases. Synonyms: 2-Amino-N6,N6-dimethyl-2'-deoxy-2'-fluoro-β-D-arabino-adenosine; (2R,3R,4S,5R)-5-[2-amino-6-(dimethylamino)purin-9-yl]-4-fluoro-2-(hydroxymethyl)oxolan-3-ol. Grades: ≥95%. CAS No. 2171103-80-1. Molecular formula: C12H17FN6O3. Mole weight: 312.30. | |
| 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4, 5-b]pyridin-2-yl) amino]-6-O- (phenylmethyl) guanosine | 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4, 5-b]pyridin-2-yl) amino]-6-O- (phenylmethyl) guanosine is an intermediate in the synthesis of 2-Deoxyguanosine-C8 adducts with mutagenic/carcinogenic heterocyclic amines. Group: Biochemicals. Grades: Highly Purified. CAS No. 896719-58-7. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H57N9O4Si2. US Biological Life Sciences. | Worldwide |
| 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl)amino]-6-O-(phenylmethyl)guanosine | 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl)amino]-6-O-(phenylmethyl)guanosine is an intermediate in the synthesis of 2'-Deoxyguanosine-C8 adducts with mutagenic/carcinogenic heterocyclic amines. CAS No. 896719-58-7. Molecular formula: C42H57N9O4Si2. Mole weight: 808.13. | |
| 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4, 5-b]pyridin-2-yl) amino]-guanosine | 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-8-[ (1-methyl-6-phenyl-1H-imidazo[4, 5-b]pyridin-2-yl) amino]-guanosine is an intermediate in the synthesis of 2-Deoxyguanosine-C8 adducts with mutagenic/carcinogenic heterocyclic amines. Group: Biochemicals. Grades: Highly Purified. CAS No. 915092-62-5. Pack Sizes: 1mg, 5mg. Molecular Formula: C35H51N9O4Si2. US Biological Life Sciences. | Worldwide |
| 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl)amino]-guanosine | 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl)amino]-guanosine is an intermediate in the synthesis of 2'-Deoxyguanosine-C8 adducts with mutagenic/carcinogenic heterocyclic amines. Synonyms: 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl)amino]-guanosine; 915092-62-5. CAS No. 915092-62-5. Molecular formula: C35H51N9O4Si2. Mole weight: 718.01. | |
| 3',5'-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]-6-O-benzyl-guanosine | Used in the preparation of 2'-Deoxyguanosine-C8 adducts. Synonyms: 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-8-[(3,8-dimethyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]-6-O-(phenylmethyl)-guanosine. CAS No. 896719-54-3. Molecular formula: C40H56N10O4Si. Mole weight: 797.11. | |
| 3,5-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]-6-O-benzyl-guanosine | Used in the preparation of 2'-Deoxyguanosine-C8 adducts. Group: Biochemicals. Alternative Names: 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-8-[ (3, 8-dimethyl-3H-imidazo[4, 5-f]quinoxalin-2-yl) amino]-6-O- (phenylmethyl) -guanosine. Grades: Highly Purified. CAS No. 896719-54-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 3',5'-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Synonyms: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Molecular formula: C33H50N10O4Si2. Mole weight: 706.99. | |
| 3,5-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx (D29615) derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| 3',5'-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx-d3 derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Synonyms: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3. Molecular formula: C33H47D3N10O4Si2. Mole weight: 710. | |
| 3,5-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx-d3 derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2-deoxy-3,5-di-O-toluoyl-a,b-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2-deoxy-3,5-di-O-toluoyl-a-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-a-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-a-D-ribofuranosyl)-7-pteridone, a remarkable compound in the biomedical field, exhibits unparalleled efficacy as an antiviral marvel. Its utilization in combating infections induced by select RNA viruses has led to groundbreaking advancements. This potent agent operates with astonishing precision, impeding the synthesis of viral nucleic acids and thus decimating viral replication. Its spectrally diverse actions against multifarious viral maladies manifest unparalleled potential, propelling the frontiers of antiviral research and therapeutic applications. Molecular formula: C29H29N5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-a-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-a-D-ribofuranosyl)-7-pteridone. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 1mg, 2mg, 5mg, 10mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-α,β-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Molecular formula: C29H29N5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-α-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Molecular formula: C29H29N5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2-deoxy-3,5-di-O-toluoyl-b-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-b-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-b-D-ribofuranosyl)-7-pteridone, a compound of utmost importance in biomedicine, showcases remarkable potential in combatting various ailments by efficiently targeting specific drugs or pathways. Delving into the realms of its precise functionality and therapeutic applications unveils a vast expanse of enlightenment through the provision of comprehensive web-based resources. Molecular formula: C29H29H5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-b-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-b-D-ribofuranosyl)-7-pteridone. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 1mg, 2mg, 5mg, 10mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-β-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue. Molecular formula: C29H29N5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-D-ribofuranosyl)-7-pteridone, a promising antineoplastic agent, boasts remarkable efficacy against a wide range of solid tumors, leukemias, and lymphomas by stymying DNA synthesis, impairing replication of cancer cells. Molecular formula: C29H29N5O6. Mole weight: 543.57. | |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-3',5'-di-O-toluoyl-D-ribofuranosyl)-7-pteridone. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2mg, 5mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2-deoxy-b-D-ribofuranosyl)-7(8H)-pteridone (DMAP) | A highly fluorescent adenosine analogue, which in a dimethoxytrityl, phosphoramidite protected form, can be site-specifically inserted into oligonucleotides through a 3,5-phosphodiester linkage using an automated DNA synthesizer. Group: Biochemicals. Alternative Names: DMAP. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-b-D-ribofuranosyl)-7-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-b-D-ribofuranosyl)-7-pteridone. Group: Biochemicals. Grades: Highly Purified. CAS No. 195442-56-9. Pack Sizes: 1mg, 5mg, 10mg. Molecular Formula: C13H17N5O4. US Biological Life Sciences. | Worldwide |
| 4-Amino-2,6-dimethyl-8-(2'-deoxy-β-D-ribofuranosyl)-7(8H)-pteridone | A highly fluorescent adenosine analogue, which in a dimethoxytrityl, phosphoramidite protected form, can be site-specifically inserted into oligonucleotides through a 3',5'-phosphodiester linkage using an automated DNA synthesizer. Uses: A highly fluorescent adenosine analogue, which in a dimethoxytrityl, phosphoramidite protected form, can be site-specifically inserted into oligonucleotides through a 3',5'-phosphodiester linkage using an automated dna synthesizer. Synonyms: 4-Amino-8-(2-deoxy-β-D-erythro-pentofuranosyl)-2,6-dimethyl-7(8H)pteridinone; DMAP. CAS No. 195442-56-9. Molecular formula: C13H17N5O4. Mole weight: 307.31. | |
| 5'-Amino-5'-deoxy-N-[(1,1-dimethylethoxy)carbonyl]-2',3'-O-(1-methylethylidene)-adenosine | 5'-Amino-5'-deoxy-N-[(1,1-dimethylethoxy)carbonyl]-2',3'-O-(1-methylethylidene)-adenosine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 873556-45-7, 5-amino-5-deoxy-N-[(1,1-dimethylethoxy)carbonyl]-2,3-O-(1-methylethylidene)-Adenosine. Product Category: Heterocyclic Organic Compound. CAS No. 873556-45-7. Molecular formula: C18H26N6O5. Mole weight: 406.436240 [g/mol]. Purity: 0.96. IUPACName: tert-butyl N-[9-[(3aS,4R,6R)-6-(aminomethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]purin-6-yl]carbamate. Product ID: ACM873556457. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Adenosine, 3'-?deoxy-?2'-?O-?[ (1, ?1-?dimethylethyl) ?dimethylsilyl]?-?3'-?[[ (4-?methoxyphenyl) ?diphenylmethyl]?amino]?-?N-? (2-?phenoxyacetyl) ?-?2-?[ (2-?phenoxyacetyl) ?amino]?-?, 5'-?[2-?cyanoethyl N,?N-?bis(1-?methylethyl)?phosphoramidite] | Adenosine, 3'-deoxy-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-3'-[[(4-methoxyphenyl)diphenylmethyl]amino]-N-(2-phenoxyacetyl)-2-[(2-phenoxyacetyl)amino]-, 5'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], a chemical compound highly employed as a reagent in oligonucleotide synthesis for biomedical research, as well as in the development of pharmacological interventions aimed at treating several cancers and viral infections, amongst them hepatitis B. Synonyms: Adenosine, 3'-deoxy-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-3'-[[(4-methoxyphenyl)diphenylmethyl]amino]-N-(phenoxyacetyl)-2-[(phenoxyacetyl)amino]-, 5'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI). CAS No. 256485-55-9. Molecular formula: C61H74N9O9PSi. Mole weight: 1136.35. | |
| Cytidine, N-?benzoyl-?3'-?deoxy-?2'-?O-?[ (1, ?1-?dimethylethyl) ?dimethylsilyl]?-?3'-?[[ (4-?methoxyphenyl) ?diphenylmethyl]?amino]?-?, 5'-?[2-?cyanoethyl bis(1-?methylethyl)?phosphoramidite] (9CI) | Cytidine, N-benzoyl-3'-deoxy-2'-O-[ (1, ?1-dimethylethyl) ?dimethylsilyl]?-3'-[[ (4-methoxyphenyl) ?diphenylmethyl]?amino]?-, 5'-[2-cyanoethyl bis(1-methylethyl)?phosphoramidite] (9CI) exhibits significant antiviral properties against various infections, including hepatitis C virus (HCV) and HIV. Mechanistically, its efficacy is due to mimicking nucleosides found in RNA, thereby halting viral replication. Notably, it represents a crucial nucleoside analogue for RNA interference (RNAi) and antisense therapy, with the added benefit of broad-spectrum antiviral activity. This product is an essential tool for researchers, clinicians, and virologists in developing effective pharmaceutical interventions for viral infections. Synonyms: ( (2S, 3R, 4R, 5R) -5- (4-benzamido-2-oxopyrimidin-1 (2H) -yl) -4- ( (tert-butyldimethylsilyl) oxy) -3- ( ( (4-methoxyphenyl) diphenylmethyl) amino) tetrahydrofuran-2-yl) methyl (2-cyanoethyl) diisopropylphosphoramidite. CAS No. 256485-58-2. Molecular formula: C51H65N6O7PSi. Mole weight: 933.16. | |
| n2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline | n2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2'-Deoxy-8-[(3,8-dimethyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine; dG-C8-MeIQx. Product Category: Heterocyclic Organic Compound. Appearance: Yellow Solid. CAS No. 142038-31-1. Molecular formula: C21H22N10O4. Mole weight: 478.46. Purity: 0.96. IUPACName: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Density: 1.93g/cm³. Product ID: ACM142038311. Alfa Chemistry ISO 9001:2015 Certified. | |
| N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline | MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: 2'-Deoxy-8-[(3,8-dimethyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine; dG-C8-MeIQx. Grades: Highly Purified. CAS No. 142038-31-1. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline | MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Synonyms: 2'-Deoxy-8-[(3,8-dimethyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine; dG-C8-MeIQx. Grades: 96%. CAS No. 142038-31-1. Molecular formula: C21H22N10O4. Mole weight: 478.46. | |
| N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3 | Labeled dG-C8-MeIQx. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: 2'-Deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine; dG-C8-MeIQx-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| O-3-Deoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-D-glucopyranosyl-(1?6)-O-[2,3,6-trideoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-N3-[(1,1-dimethylethoxy)carbonyl]-D-streptamine | O-3-Deoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-D-glucopyranosyl-(1?6)-O-[2,3,6-trideoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-N3-[(1,1-dimethylethoxy)carbonyl]-D-streptamine is an intermediate used in the synthesis of 1-N-Ureido Tobramycin Tetrahydrochloride Salt, a related compound of Tobramycin, single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial. Synonyms: O-3-Deoxy-3-[(trifluoroacetyl)amino]-α-D-glucopyranosyl-(1?6)-O-[2,3,6-trideoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-N3-[(1,1-dimethylethoxy)carbonyl]-D-streptamine. CAS No. 502610-98-2. Molecular formula: C35H60F3N5O16. Mole weight: 863.87. | |
| Uridine, 2'-?amino-?2'-?deoxy-?4'-?C-?[[[ (1, ?1-?dimethylethyl) ?diphenylsilyl]?oxy]?methyl]?-?5-?methyl-?3', ?5'-?bis-?O-? (phenylmethyl) ?- | Uridine, 2'-amino-2'-deoxy-4'-C-[[[ (1, ?1-dimethylethyl) ?diphenylsilyl]?oxy]?methyl]?-5-methyl-3', ?5'-bis-O- (phenylmethyl) ?- is a biomedical product used in the research of viral diseases and cancers. It acts as an antiviral compound by inhibiting viral replication. Synonyms: 2'-Amino-2'-deoxy-4'-C-[[[ (1, 1-dimethylethyl) diphenylsilyl]oxy]methyl]-5-methyl-3', 5'-bis-O- (phenylmethyl) uridine. CAS No. 1300589-99-4. Molecular formula: C41H47N3O6Si. Mole weight: 705.91. | |
| 2-Amino-4-chloro-5-iodo-N2-pivaloyl-7-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-b-D-ribofuanosyl]-7H-pyrrolo[2,3-d]pyrimidine | 2-Amino-4-chloro-5-iodo-N2-pivaloyl-7-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-b-D-ribofuanosyl]-7H-pyrrolo[2,3-d]pyrimidine is characterized by its substantial potential in restraining cancer cell propagation, of which kinascetic inhibitory activity directs its attention towards blocking cancer cell proliferation enzymes. Synonyms: chloro-7-[2-deoxy-3,5-di-O-(4-toluoyl)-β-D-erythro-pentofuranosyl]-5-iodo-2-pivaloylamino-7H-pyrrolo[2,3-d]pyrimidine; [(2R,3S,5R)-5-[4-chloro-2-(2,2-dimethylpropanoylamino)-5-iodopyrrolo[2,3-d]pyrimidin-7-yl]-3-(4-methylbenzoyl)oxyoxolan-2-yl]methyl 4-methylbenzoate. Grades: ≥95%. CAS No. 199938-73-3. Molecular formula: C32H32ClIN4O6. Mole weight: 730.98. | |
| 2-Amino-4-chloro-N2-pivaloyl-7-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-b-D-ribofuanosyl]-7H-pyrrolo[2,3-d]pyrimidine | 2-Amino-4-chloro-N2-pivaloyl-7-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-b-D-ribofuanosyl]-7H-pyrrolo[2,3-d]pyrimidine is a highly complex and multifaceted chemical compound, which shows great promise in the realm of modern medicinal science. This compound has been shown to be extremely effective in the fight against certain types of cancers, where it can effectively inhibit tumor growth and induce apoptosis. Furthermore, it has demonstrated potent inhibition of viral replication, presenting a potential path forward for the treatment of notoriously difficult-to-treat viral infections. Synonyms: [(2R,3S,5R)-5-[4-chloro-2-(2,2-dimethylpropanoylamino)-pyrrolo[2,3-d]pyrimidin-7-yl]-3-(4-methylbenzoyl)oxyoxolan-2-yl]methyl 4-methylbenzoate. Grades: ≥95%. CAS No. 1878120-03-6. Molecular formula: C32H33ClN4O6. Mole weight: 605.08. | |
| 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-5-[[[ (1, 1-dimethylethyl) dimethylsilyl]oxy]methyl]cytidine | 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-5-[[[ (1, 1-dimethylethyl) dimethylsilyl]oxy]methyl]cytidine is an intermediate in the synthesis of modified pyrimidine that is capable of producing interstrand cross-links in duplex DNA. 4-(Hydroxymethyl)-2'-deoxycytidine can be analyzed to quantify DNA hydroxymethylation levels in biological samples. Synonyms: 2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-5-[[[ (1, 1-dimethylethyl) dimethylsilyl]oxy]methyl]cytidine; 4-Amino-1-[4-[tert-butyl (dimethyl)silyl]oxy-5-[[tert-butyl (dimethyl)silyl]oxymethyl]oxolan-2-yl]-5-[[tert-butyl (dimethyl)silyl]oxymethyl]pyrimidin-2-one; 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-5-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]me. CAS No. 1210427-82-9. Molecular formula: C28H57N3O5Si3. Mole weight: 600.03. | |
| 2'-Deoxy-3,5-dimethylcytidine | 2'-Deoxy-3,5-dimethylcytidine is involved in the biosynthesis of albomycin δ2 for the purpose of providing a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates. Group: Biochemicals. Grades: Highly Purified. CAS No. 198198-29-7. Pack Sizes: 1mg, 5mg. Molecular Formula: C11H17N3O4, Molecular Weight: 255.27. US Biological Life Sciences. | Worldwide |
| 2'-?Deoxy-?5'-?O-?[ (1, ?1-?dimethylethyl) ?dimethylsilyl]?-?2', ?2'-?difluorocytidine | 2'-Deoxy-5'-O-[(1, 1-dimethylethyl)dimethylsilyl]-2', 2'-difluorocytidine is an intermediate in the synthesis of Gemcitabine metabolites. Synonyms: 4-amino-1-((2R,4R,5R)-5-((tert-butyldimethylsilyloxy)methyl)-3,3-difluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 4-amino-1-[(2R,4R,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3,3-difluoro-4-hydroxyoxolan-2-yl]pyrimidin-2-one; 2'-Deoxy-5'-O-[(1, 1-dimethylethyl)dimethylsilyl]-2', 2'-difluorocytidine; 5'-O-(t-butyldimethylsilyl)-2'-deoxy-2',2'-difluorocytidine; 4-Amino-1-((2R,4R,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-3,3-difluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidin-2(1H)-one. CAS No. 1151528-36-7. Molecular formula: C15H25F2N3O4Si. Mole weight: 377.46. | |
| 2'-Deoxy-N2-DMF-5'-O-DMT-guanosine | 2'-Deoxy-N2-DMF-5'-O-DMT-guanosine is a crucial compound extensively used in the biomedical industry. This product plays a significant role in the synthesis of nucleoside analogs and anti-viral drugs targeting diseases such as HIV and hepatitis C. Its unique chemical structure allows for further modification, making it a versatile tool in drug development and pharmaceutical research. Synonyms: 5'-DMT-DMF-dG; 2'-Deoxy-5'-O-DMT-N2-(dimethylamino)methylidene-D-guanosine; Guanosine, 5'-O-[bis(4-methoxyphenyl)?phenylmethyl]?-2'-deoxy-N-[(dimethylamino)?methylene]?-; 2'-Deoxy-N2-DMF-5'-O-DMT-D-guanosine; N2-DMF-5'-O-DMT-2'-deoxy-D-guanosine; 5'-O-DMT-N2-(dimethylamino)methylidene-2'-Deoxyguanosine; 5'-O-(4,4'-Dimethoxytrityl)-N2-dimethylformamidine-2'-deoxyguanosine; N2-Dimethylformamidine-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine; 9-{5-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxy-β-D-threo-pentofuranosyl}-2-{(E)-[(dimethylamino)methylene]amino}-1,9-dihydro-6H-purin-6-one. Grades: ≥98% by HPLC. CAS No. 40094-22-2. Molecular formula: C34H36N6O6. Mole weight: 624.70. | |
| 2N-Boc-amino-2-deoxy-b-D-galactopyranosylamine | 2N-Boc-amino-2-deoxy-b-D-galactopyranosylamine plays a pivotal role in synthesizing manifold glycoconjugates. Its versatility as a building block facilitates the creation of glycosidic bonds, thereby forging a path towards combatting targeted affliction. The inherent uniqueness of its structure empowers scientists to ingeniously engineer glycoproteins. Synonyms: β-D-Galactopyranosylamine, 2-deoxy-2-[[(1,1-dimethylethoxy)carbonyl]amino]-; 2-Deoxy-2-[[(1,1-dimethylethoxy)carbonyl]amino]-β-D-galactopyranosylamine. Molecular formula: C11H22N2O6. Mole weight: 278.30. | |
| 2N-Boc-amino-2-deoxy-b-D-glucopyranosylamine | 2N-Boc-amino-2-deoxy-b-D-glucopyranosylamine is a vital compound used in the biomedical industry acting as a building block for developing targeting specific drug-resistant pathogens and diseases related to glycosylation. Synonyms: β-D-Glucopyranosylamine, 2-deoxy-2-[[(1,1-dimethylethoxy)carbonyl]amino]-; 2-Deoxy-2-[[(1,1-dimethylethoxy)carbonyl]amino]-β-D-glucopyranosylamine. CAS No. 494201-09-1. Molecular formula: C11H22N2O6. Mole weight: 278.30. | |
| (2R) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-propylidene-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester | (2R) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-propylidene-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 25mg, 50mg. Molecular Formula: C19H37NO3Si. US Biological Life Sciences. | Worldwide |
| (2R, 4R) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-hydroxy-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester | (2R, 4R) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-hydroxy-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. CAS No. 216062-16-7. Pack Sizes: 50mg, 100mg. Molecular Formula: C16H33NO4Si. US Biological Life Sciences. | Worldwide |
| (2R,4R)-2-(Hydroxymethyl)-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester | (2R,4R)-2-(Hydroxymethyl)-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. CAS No. 1432589-42-8. Pack Sizes: 5mg, 10mg. Molecular Formula: C13H25NO3. US Biological Life Sciences. | Worldwide |
| (2R, 4R) -4-propyl -1, 2-pyrrolidinedicarboxyl ic Acid 1-(1,1-Dimethylethyl) Ester | (2R, 4R) -4-propyl -1, 2-pyrrolidinedicarboxyl ic Acid 1-(1,1-Dimethylethyl) Ester is an intermediate in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C13H23NO4. US Biological Life Sciences. | Worldwide |
| (2R,4S)-2-(Hydroxymethyl)-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-dimethylethyl Ester | (2R,4S)-4-Hydroxy-2-(hydroxymethyl)-1-pyrrolidinecarboxylic Acid 1,1-dimethylethyl Ester is an impurity in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg, 25mg. Molecular Formula: C13H25NO3. US Biological Life Sciences. | Worldwide |
| (2S, 4S) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester | (2S, 4S) -2- [ [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] methyl] -4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in the synthesis of 2-epi-Lincomycin which is an epimer of Lincomycin (L466200) which is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg, 25mg. Molecular Formula: C19H39NO3Si, Molecular Weight: 357.6. US Biological Life Sciences. | Worldwide |
| 3,4-Xylyl-6-phenylazo-D-ribitylamine | Riboflavin intermediate. Group: Biochemicals. Alternative Names: 1-Deoxy-1-[4, 5-dimethyl-2- (phenylazo) phenylamino]-D-ribitol; 1-Deoxy-1-[[4, 5-dimethyl-2- (2-phenyldiazenyl) phenyl]amino]-D-ribitol. Grades: Highly Purified. CAS No. 21037-26-3. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 3-Amino-3-deoxy-1,2:5,6-di-O-isopropylidene-a-D-glucofuranose | 3-Amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose is a pivotal pharmaceutical compound, exhibiting remarkable pharmaceutical potential owing to its presence in diverse drug formulations utilized for managing diabetes, cancer, and viral ailments. Synonyms: 3-Amino-3-deoxy-1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose; (3aS,5S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-amine; (3aS,5S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxol-6-amine; Benzoic acid, 4-fluoro-2-mercapto-; AKOS030242163; 3-Amino-3-deoxy-1,2:5,6-di-O-isopropylidene- alpha -D-glucofuranose. CAS No. 24384-84-7. Molecular formula: C12H21NO5. Mole weight: 259.3. | |
| 3'-O-tert-Butyldimethylsilyl-2'-deoxyadenosine | 3'-O-tert-Butyldimethylsilyl-2'-deoxyadenosine is a valuable reagent widely used in biomedical research, primarily utilized in the synthesis of nucleosides and nucleotides for studying DNA and RNA structures. Additionally, it finding application in drug design and discovery, targeting diseases such as cancer, viral infections is and genetic disorders. Synonyms: 3'-O-(t-Butyldimethylsilyl)-2'-deoxyadenosine; Adenosine, 2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-; ( (2R, 3S, 5R) -5- (6-Amino-9H-purin-9-yl) -3- ( (tert-butyldimethylsilyl) oxy) tetrahydrofuran-2-yl) methanol; 2'-Deoxy-3'-O-[dimethyl(2-methyl-2-propanyl)silyl]adenosine; 3'-O-TBDMS-2'-deoxyadenosine. Grades: ≥95%. CAS No. 51549-31-6. Molecular formula: C16H27N5O3Si. Mole weight: 365.50. | |
| 4-amino-1-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(chloromethyl)-3-fluorotetrahydrofuran-2-yl)pyrimidin-2(1H)-one | 4-Amino-1-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(chloromethyl)-3-fluorotetrahydrofuran-2-yl)pyrimidin-2(1H)-one represents a promising biomedical research product with great potential in the development of novel drugs targeted towards various debilitating diseases. Studies have shown that this compound has the ability to inhibit cancer cell growth and may possess antiviral and antibacterial properties. While scientists are currently investigating the specific mechanism of action and clinical uses of this compound. Synonyms: Cytidine, 4'-C-(chloromethyl)-2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-5'-O-[(1,1-dimethylethyl)diphenylsilyl]-2'-fluoro-. Grades: 97%. CAS No. 1445379-90-7. Molecular formula: C32H45ClFN3O4Si2. Mole weight: 646.34. | |
| 5'-Amino-5'-deoxy-2'-O-methyl-5-methyluridine | 5'-Amino-5'-deoxy-2'-O-methyl-5-methyluridine, a biomedical agent employed for the therapeutic management of viral ailments including hepatitis C, showcases remarkable antiviral efficacy a result of its capacity to impede viral replication. Its idiosyncratic chemical constitution enables interference with viral RNA synthesis, effectively arresting the advancement of the infection. Synonyms: 5,2'-O-Dimethyl-5'-amino-5'-deoxyuridine; Uridine, 5'-amino-5'-deoxy-5-methyl-2'-O-methyl-; 1-((2R,3R,4R,5R)-5-Aminomethyl-4-hydroxy-3-methoxy-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione. Grades: ≥95%. CAS No. 251296-69-2. Molecular formula: C11H17N3O5. Mole weight: 271.27. | |
| 5'-Deoxy-5'-(dimethylsulfonio)adenosine Bromide | 5'-Deoxy-5'-(dimethylsulfonio)denosine Bromide is a derivative of Ademethionine, and potential design inhibitor of human S-adenosylmethionine decarboxylase. Synonyms: (((2S,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)dimethylsulfonium Bromide. CAS No. 1106914-63-9. Molecular formula: C12H18BrN5O3S. Mole weight: 392.27. | |
| 5'-O-TBDMS-2'-deoxyadenosine | 5'-O-TBDMS-2'-deoxyadenosine, a synthetic nucleoside derivative, utilized in the manufacturing of anti-cancer agents and antiviral drugs. It also plays a crucial role in gene therapy research and gene expression analyses as an oligonucleotide synthesizing agent. Moreover, this exceptional compound boasts of its remarkable metabolic stability, and is renowned for its potent DNA polymerase and reverse transcriptase inhibitory effects. Synonyms: 5'-O-TBDMS-dA; Adenosine, 2'-deoxy-5'-O-[(1,1-dimethylethyl)dimethylsilyl]-; 5'-O-(tert-Butyldimethylsilyl)-2'-deoxyadenosine; (2R, 3S, 5R) -5- (6-Amino-9H-purin-9-yl) -2- ( ( (tert-butyldimethylsilyl) oxy) methyl) tetrahydrofuran-3-ol; 2'-Deoxy-5'-O-[dimethyl(2-methyl-2-propanyl)silyl]adenosine. Grades: ≥97% by HPLC. CAS No. 51549-30-5. Molecular formula: C16H27N5O3Si. Mole weight: 365.51. | |
| 5'-O-tert-Butylmethylsilyl-2'-deoxy-5-iodocytidine | 5'-O-tert-Butylmethylsilyl-2'-deoxy-5-iodocytidine is a formidable compound, exhibiting remarkable efficacy in research of an array of ailments induced by viral adversaries. Through its potent mechanism of selectively restraining viral replication, it emerges as an impactful antiviral warrior. Synonyms: 5'-tert-butyldimethylsilyloxy-5-iodo-2'-deoxycytidine; 5'-O-TBDMS-5-iodo-2'-deoxycytidine; 2'-Deoxy-5'-O-[(1,1-dimethylethyl)dimethylsilyl]-5-iodo-Cytidine; 4-Amino-1-((2R,4S,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one; 5-TBDMS-5-I-2-dC. Grades: ≥97% by HPLC. CAS No. 666848-11-9. Molecular formula: C15H26IN3O4Si. Mole weight: 467.38. | |
| 5'-tert-Butyldimethylsilyloxy-2'-deoxyguanosine | 5'-tert-Butyldimethylsilyloxy-2'-deoxyguanosine, a modified guanosine, is a pivotal compound in biomedical research, facilitating DNA synthesis. It provides an ideal substrate for DNA polymerases while also being a key ingredient in nucleic acids chemistry, useful in exploring the relationship between DNA damage and cancer. Additionally, its application as a tool to focus on the structure-function links of DNA-repair enzymes has been extensive, unveiling novel research opportunities. Synonyms: 5'-O-TBDMS-2'-deoxyguanosine; 2-Amino-9-((2R,4S,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 5'-O-TBDMS-dG; 2'-Deoxy-5'-O-[dimethyl(2-methyl-2-propanyl)silyl]guanosine. Grades: ≥97% by HPLC. CAS No. 51549-33-8. Molecular formula: C16H27N5O4Si. Mole weight: 381.51. | |
| 6-Amino-6-deoxy-1,2-O-isopropylidene-a-D-glucofuranose HCl | 6-Amino-6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose hydrochloride is a renowned biomedical substance, finding its application in the research of viral infections and malignant tumors. Its utmost significance arises from its competence as a pivotal intermediary during the fabrication of diverse pharmaceuticals intended to target viral compounds or malignant neoplasms. Synonyms: (3aR,5R,6aS)-5-(2-amino-1-hydroxyethyl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol; hydrochloride; 24384-88-1; 6-Amino-6-deoxy-1,2-O-isopropylidene-alpha-D-glucofuranose Hydrochloride; DTXSID60675571; J-015481. CAS No. 24384-88-1. Molecular formula: C9H17NO5.HCl. Mole weight: 255.70. | |
| 6-Fluorescein dT phosphoramidite | 6-Fluorescein dT phosphoramidite can be inserted into the desired sequence as a replacement for a dT residue during oligonucleotides synthesis. Synonyms: Uridine, 5-[3-[[6-[[[3',6'-bis(2,2-dimethyl-1-oxopropoxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-6-yl]carbonyl]amino]hexyl]amino]-3-oxo-1-propen-1-yl]-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; 5'-Dimethoxytrityloxy-5-[N-((3',6'-dipivaloylfluoresceinyl)-aminohexyl)-3-acrylimido]-2'-deoxyuridine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; Fluorescein-dT Phosphoramidite; Fluorescein dT CEP. Grades: ≥95%. CAS No. 1194507-30-6. Molecular formula: C79H89N6O17P. Mole weight: 1425.56. | |
| 6-O-Benzoyl-D-glucal | 6-O-Benzoyl-D-glucal, an indispensable chemical compound in the biomedical sector, demonstrates profound significance for synthesizing diverse pharmaceutical remedies. Its intricate framework and distinct attributes render it a potential breakthrough in combating ailments like cancer, diabetes, and inflammation. Synonyms: ((2R,3S,4R)-3,4-Dihydroxy-3,4-dihydro-2H-pyran-2-yl)methyl benzoate; 6-O-benzoylglucal; [(2R,3S,4R)-3,4-dihydroxy-3,4-dihydro-2H-pyran-2-yl]methyl benzoate; SCHEMBL9091396; DIEYDTYJOXFFJG-UTUOFQBUSA-N; D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-, 6-benzoate; AKOS015916617; A923834; N-(6-aminopyridin-2-yl)-2,2-dimethylpropionamide. CAS No. 58871-05-9. Molecular formula: C13H14O5. Mole weight: 250.25. | |
| 8-Amino[1''-(N''-dansyl)-4''-aminobutyl]-5'-(1-aziridinyl)-5'-deoxy Adenosine | A fluorescent cofactor reagent for the sequence-specific labeling of DNA methyltransferase from Thermus aquaticus (M*Taql). It binds about 4-fold better than the natural cofactor AdoMet to M*Taql. In addition, the reagent can be used to sequence-specifically label plasmid DNA in a M*Taql-catalyzed reaction. Synonyms: 9-[(2xi)-5-(Aziridin-1-yl)-5-deoxy-beta-D-threo-pentofuranosyl]-N~8~-(4-{[5-(dimethylamino)naphthalene-1-sulfonyl]amino}butyl)-9H-purine-6,8-diamine; N-[4-[[6-amino-9-[(2R,4R,5R)-5-(aziridin-1-ylmethyl)-3,4-dihydroxyoxolan-2-yl]purin-8-yl]amino]butyl]-5-(dimethylamino)naphthalene-1-sulfonamide; 8-Amino[1"-(N"-dansyl)-4"-aminobutyl]-5'-(1-aziridinyl)-5'-deoxy Adenosine; DTXSID90675569; 8-Amino[1 inverted exclamation mark+/--(N inverted exclamation mark+/--dansyl)-4 inverted exclamation mark+/--aminobutyl]-5 inverted exclamation mark -(1-aziridinyl)-5 inverted exclamation mark -deoxy Adenosine. Grades: > 95%. CAS No. 256953-68-1. Molecular formula: C28H37N9O5S. Mole weight: 611.72. | |
| 8-Amino-2'-deoxy-N6,N8-di-DMF-5'-O-DMT-adenosine 3'-CE phosphoramidite | 8-Amino-2'-deoxy-N6,N8-di-DMF-5'-O-DMT-adenosine 3'-CE phosphoramidite is a vital component used in the research and development of oligonucleotides for drug discovery. It offers efficient coupling to ensure accurate incorporation of adenosine nucleotides during the solid-phase research and development process. Synonyms: 5'-Dimethoxytrityl-N6,N8-bis(dimethylaminomethylidine)-8-amino-2'-deoxyAdenosine, 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 8-Amino-dA-CE Phosphoramidite; 8-Amino-2'-deoxy-D-adenosine 3'-CE phosphoramidite. CAS No. 211676-21-0. Molecular formula: C46H59N10O6P. Mole weight: 879.01. | |
| Adenosine (9- β-D-ribofuranosyladenine, Adenine riboside, Adenine-9- β-D-ribofuranoside) | In the extracellular space, ecto-5?-nucleotidase (CD73) dephosphorylates adenosine triphosphate (ATP) to produce adenosine. Adenosine has four receptors namely A1R, A2AR A2BR and A3R. Adenosine plays a key role in the osteogenic differentiation. A1R induces osteoclast differentiation and A2AR induces osteoblast differentiation. Adenosine has been used: as a supplement in embryonic type culture medium for in vitro osteogenic differentiation for evaluation of its effect on cell survival by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT assay) and cell proliferation by 3H-thymidine incorporation assay in multi drug resistant glioblastoma stem-like cells (GSCs), and as a standard in high performance liquid chromatography (HPLC). as a constituent in collagenase solution for the collagenase digestion of mice fat tissue. Group: Biochemicals. Alternative Names: 9- β-D-Ribofuranosyl-9H-purin-6-amine; 9- β-D-Ribofuranosyladenine; Adenine Riboside; Adenocard; Adenocor; Adenogesic; Adenoscan; Adrekar; Boniton; D-Adenosine; 1-(6-Amino-9H-purin-9-yl)-1-deoxy- β-D-ribofuranose; Myocol; NSC 7652. Grades: Molecular Biology Grade. CAS No. 58-61-7. Pack Sizes: 100g, 500g. Molecular Formula: C10H13N5O4, Molecular Weight: 267.25. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
